• (What's the story) morning glory? MRI findings in morning glory disc anomaly
• A novel stop-gain <em>NF1</em> variant in neurofibromatosis type 1 and bilateral optic atrophy without optic gliomas
• A novel stop-gain NF1 variant in neurofibromatosis type 1 and bilateral optic atrophy without optic gliomas
• A sellar-suprasellar malignant optic pathway glioblastoma in the absence of prior radiation therapy: illustrative case
• Acquired myelinated retinal nerve fiber layer in a child with neurofibromatosis 1-related optic pathway glioma
• An Isolated Case of Unilateral Macro-Ophthalmia With Resultant Anisometropic Amblyopia in Neurofibromatosis 1
• An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies
• An unusual presentation of bilateral optic pathway glioma in Crouzon Syndrome
• Analysis of visual evoked potentials in patients with neurofibromatosis type 1: new concepts
• Anti-seizure effect of MEK inhibitor in a child with neurofibromatosis type 1 - developmental and epileptic encephalopathy and optic pathway glioma
• Antiseizure effect of MEK inhibitor in a child with neurofibromatosis type 1-Developmental and epileptic encephalopathy and optic pathway glioma
• Arterial spin labelling: predictive role in surgical bleeding of paediatric optic pathway gliomas
• Automatic Visual Acuity Loss Prediction in Children with Optic Pathway Gliomas using Magnetic Resonance Imaging
• Bilateral visual pathway invasion of occipital astrocytoma: a case report
• Carboplatin desensitization in the era of target therapies: still worthwhile?
• Case report: Slipped capital femoral epiphysis: a rare adverse event associated with FGFR tyrosine kinase inhibitor therapy in a child
• Challenges in treating children with optic pathway gliomas: an 18-year experience from a middle-income country
• Characteristics of primary ocular symptoms in children with optic pathway glioma at different ages
• Clinical signs and genetic evaluation of patients with neurofibromatosis type 1 with and without optic pathway gliomas in a center in Turkey
• Comparison of MRI findings of hypothalamic-optic chiasmatic gliomas and craniopharyngiomas
• Complications and visual outcomes following surgical resection of pediatric optic pathway/hypothalamic gliomas: a systematic review and meta-analysis
• Corrigendum to: Identifying risk factors for recurrence/relapse in NF1 optic pathway gliomas: Moving forward by looking back
• Corrigendum: A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy <em>in vivo</em>
• Corrigendum: A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo
• Deficits in naming pictures of objects are associated with glioma infiltration of the inferior longitudinal fasciculus: A study with diffusion MRI tractography, volumetric MRI, and neuropsychology
• DRI Triton SS-OCT applied to detect choroidal nodules in paediatric patients affected by NF1
• Effectiveness of Gold Nanorods of Different Sizes in Photothermal Therapy to Eliminate Melanoma and Glioblastoma Cells
• Endoscopic debulking canalization for optic pathway glioma with obstructive hydrocephalus
• Epidemiology and Outcomes of Neurofibromatosis Type 1 (NF-1): Multicenter Tertiary Experience
• Estrogen-induced glial IL-1beta mediates extrinsic retinal ganglion cell vulnerability in murine Nf1 optic glioma
• Estrogen-induced glial IL-1β mediates extrinsic retinal ganglion cell vulnerability in murine Nf1 optic glioma
• Evaluating the impact of tubular retractors in glioma surgery: A systematic review and meta-analysis
• Evaluation of Pathway to Diagnosis of Pediatric Brain Tumors in Tamil Nadu, India
• Excessive Lipid Production Shapes Glioma Tumor Microenvironment
• Excessive lipid production shapes glioma tumor microenvironment
• Genotype-Phenotype Correlation in Neurofibromatosis Type 1: Evidence for a Mild Phenotype Associated with Splicing Variants Leading to In-Frame Skipping of <em>NF1</em> Exon 24 [19a]
• Imaging glymphatic response to glioblastoma
• Immunotherapy for pediatric low-grade gliomas
• Inhibition of exosome biogenesis affects cell motility in heterogeneous sub-populations of paediatric-type diffuse high-grade gliomas
• Insights into Novel Choroidal and Retinal Clinical Signs in Neurofibromatosis Type 1
• Intraoperative Neuromonitoring of the Visual Pathway in Asleep Neuro-Oncology Surgery
• Is proton beam therapy always better than photon irradiation? Lessons from two cases
• Laser interstitial thermal therapy is effective and safe for the treatment of brain tumors in NF1 patients after cerebral revascularization for moyamoya angiopathy: a report on two cases
• Leveraging murine models of the neurofibromatosis type 1 cancer predisposition syndrome to elucidate the cellular circuits that drive pediatric low-grade glioma formation and progression
• Long-term outcomes of symptomatic optic pathway glioma: 32-year experience at a single Western Australian tertiary pediatric oncology center
• Longitudinal changes in retinal ganglion cell function in optic pathway glioma evaluated by photopic negative response
• Low-grade glioma in children with neurofibromatosis type 1: surveillance, treatment indications, management, and future directions
• Magnetic resonance imaging characteristics of glioblastoma of the optic pathway during adulthood
• Maternal obesogenic diet operates at the tumor cell of origin to increase incidence and decrease latency of Neurofibromatosis Type 1 optic pathway glioma
• Meningeal macrophages inhibit chemokine signaling in pre-tumor cells to suppress mouse medulloblastoma initiation
• Multichannel-optical imaging for in vivo evaluating the safety and therapeutic efficacy of stem cells in tumor model in terms of cell tropism, proliferation and NF-kappaB activity
• Multimodal study of multilevel pulvino-temporal connections: a new piece in the puzzle of lexical retrieval networks
• Navigating the complexities of encephalocraniocutaneous lipomatosis: a case series and review
• Neurofibromatosis Type 1-Associated Optic Pathway Gliomas: Current Challenges and Future Prospects
• Neurofibromatosis type 1-associated optic pathway gliomas: pathogenesis and emerging treatments
• Neurosurgical morbidity in pediatric supratentorial midline low-grade glioma: Results from the German LGG studies
• NF1 mutation-driven neuronal hyperexcitability sets a threshold for tumorigenesis and therapeutic targeting of murine optic glioma
• Novel therapeutic approaches for pediatric diencephalic tumors: improving functional outcomes
• Novel treatments in optic pathway gliomas
• Ophthalmologic Findings in Children with Neurofibromatosis Type 1
• Optic Pathway Gliomas in Pediatric Population-Current Approach in Diagnosis and Management: Literature Review
• Optic pathway gliomas: Long-term outcomes and challenges
• Optic Pathway Gliomas: The Trends of Basic Research to Reduce the Impact of the Disease on Visual Function
• Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas
• Optical Genome Mapping: Integrating Structural Variations for Precise Homologous Recombination Deficiency Score Calculation
• Pathophysiological evaluation of pilocytic astrocytoma in adults: Histopathological and immunohistochemical analysis
• Pediatric Optic Pathway Gliomas Resource Utilization and Prevalence in the OptumLabs Data Warehouse
• Pediatric Optic Pathway Gliomas: A Report From Northern Greece
• Phenotype and Genotype of Saudi Pediatric Patients With Neurofibromatosis Type 1: A Seven-Year Multicenter Experience From Saudi Arabia
• Photobiomodulation Recovers the Submandibular Gland in Vismodegib-Treated Rats
• Pilocytic Astrocytoma
• Pilose antler extract promotes hair growth in androgenic alopecia mice by promoting the initial anagen phase
• Prechiasmatic Transection of the Unilateral Dodge Class Ⅰ Optic Pathway Glioma without Neurofibromatosis Type 1: Technical Description and Clinical Prognosis
• Prechiasmatic Transection of the Unilateral Dodge Class Optic Pathway Glioma without Neurofibromatosis Type 1: Technical Description and Clinical Prognosis
• Prechiasmatic transection of the unilateral Dodge ClassesⅠoptic pathway glioma (OPG-uDCⅠ) without neurofibromatosis type 1 (NF1): technical description and clinical prognosis
• Primary anterior visual pathway germinoma in a 13-year-old boy: A case report
• Retinal Reactive Astrocytic Tumor and Astrocytic hamartomas in patient with Neurofibromatosis type 1: Case Report and Literature review
• Simulated microgravity induces DNA damage concurrent with impairment of DNA repair and activation of cell-type specific DNA damage response in microglial and glioblastoma cells
• Single-cell analysis of 5-aminolevulinic acid intraoperative labeling specificity for glioblastoma
• Solitary isolated disseminations of glioblastoma to sellar and suprasellar regions: two case reports
• Sonoporation-assisted micelle delivery in subcutaneous glioma-bearing mice evaluated by PET/fluorescent bi-modal imaging
• Surgical options of chiasmatic hypothalamic glioma-a relevant part of therapy in an interdisciplinary approach for tumor control
• The Endonasal Endoscopic Transsphenoidal Approach to Paediatric Optic Chiasma Glioma: A Case Report and Literature Review
• The impact of changes in gadolinium-enhancement on disease progression in children with neurofibromatosis type 1-associated optic pathway glioma: a retrospective analysis
• The management of neurofibromatosis type 1 (NF1) in children and adolescents
• The Neuroimmune Regulation and Potential Therapeutic Strategies of Optic Pathway Glioma
• The Present and Future of Optic Pathway Glioma Therapy
• The rare case of optic nerve cavernoma: A case report depicting the diagnostic challenge
• The Relationship Between Choroidal Abnormalities and Visual Outcomes in Pediatric Patients With NF1-Associated Optic Pathway Gliomas
• The Role Gut Microbiota in Glaucoma Progression and Other Retinal Diseases
• The Role of Gut Microbiota in Glaucoma Progression and Other Retinal Diseases
• The role of surgery for optic pathway gliomas in the era of precision medicine
• Transorbital neuroendoscopy-assisted resection of a giant optic pathway glioma in a neonate
• Treatment evaluation by volumetric segmentation in pediatric optic pathway glioma: evaluation of the effect of bevacizumab on intra-tumor components
• Unraveling the blue shift in porphyrin fluorescence in glioma: The 620 nm peak and its potential significance in tumor biology
• Very long-term outcomes of pediatric patients treated for optic pathway gliomas: A longitudinal cohort study
• Very long-term outcomes of pediatric patients treated for optic pathway gliomas: A longitudinal cohort study
• Visual Deficits and Diagnostic and Therapeutic Strategies for Neurofibromatosis Type 1: Bridging Science and Patient-Centered Care
• Visual deterioration outcomes following optic pathway glioma treatment: a 12-year single institution retrospective study
• Visual outcomes after bevacizumab-based therapy for optic pathway glioma